Pharmacokinetic and Ocular Toxicity Evaluation of Latanoprost Ophthalmic Solution, 0.005%, with Preservative Level Reduced to Below the Limit of Quantitation
Journal of Ocular Pharmacology and Therapeutics · 2023
DOI: 10.1089/jop.2023.0050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2023. Verfasst von Srini Venkatesh und 1 weiteren Autor:innen. Beteiligte Einrichtung: TearClear, Princeton, NJ, USA. Hauptthemen laut MEDLINE: Prostaglandins F, Synthetic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- TearClear, Princeton, NJ, USA.
- Iuvo Bioscience, Rush, New York, USA.
Zitieren
APA
Venkatesh, S., & Richardson, M. (2023). Pharmacokinetic and Ocular Toxicity Evaluation of Latanoprost Ophthalmic Solution, 0.005%, with Preservative Level Reduced to Below the Limit of Quantitation. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2023.0050
Vancouver
Venkatesh S, Richardson M. Pharmacokinetic and Ocular Toxicity Evaluation of Latanoprost Ophthalmic Solution, 0.005%, with Preservative Level Reduced to Below the Limit of Quantitation. Journal of Ocular Pharmacology and Therapeutics. 2023. doi:10.1089/jop.2023.0050
BibTeX
@article{Venkatesh2023,
author = {Venkatesh, Srini and Richardson, Mary},
title = {Pharmacokinetic and Ocular Toxicity Evaluation of Latanoprost Ophthalmic Solution, 0.005%, with Preservative Level Reduced to Below the Limit of Quantitation},
journal = {Journal of Ocular Pharmacology and Therapeutics},
year = {2023},
doi = {10.1089/jop.2023.0050}
}
EUVIMED